Atlantic Edge Private Wealth Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 2011145
JACKSONVILLE, FL
Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$9,475
-$977 QoQ
Shares Held
75
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,186
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlantic Edge Private Wealth Management, LLC holds $6,040,146 across 12 Drug Manufacturers - General names. GILD ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
17,433 | $2,240,140 | |
| 2 | LLY |
ELI LILLY & Co
|
1,291 | $1,548,464 | |
| 3 | JNJ |
Johnson & Johnson
|
3,045 | $773,338 | |
| 4 | ABBV |
AbbVie Inc.
|
2,417 | $608,213 | |
| 5 | NVS |
Novartis AG
|
2,270 | $355,754 | |
| 6 | AMGN |
Amgen Inc
|
923 | $334,236 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,650 | $95,073 | |
| 8 | AZN |
Astrazeneca PLC
|
207 | $39,251 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,475 | 75 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $10,452 | 75 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $9,205 | 75 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $8,325 | 75 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $8,315 | 75 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||